Srn Meditech Private Limited
Pharmaceutical trading and manufacturing of medicines, healthcare products, and dietary supplements.
2013 | Moradabad, Uttar Pradesh (India) | Active
Srn Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.05 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
- Revenue Growth -1.41%
- Profit Growth -1.11%
- Ebitda -72.06%
- Net Worth 10.15%
- Total Assets 3.95%
About Srn Meditech
Srn Meditech Private Limited (SMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 March 2013 and has a history of 11 years and 11 months. Its registered office is in Moradabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.05 M.
The company currently has active open charges totaling ₹3.00 Cr.
Ashi Agarwal, Nishant Agarwal, Sanjay Agarwal, and One other member serve as directors at the Company.
Company Details
- Location
Moradabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900UP2013PTC055520
- Company No.
055520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Srn Meditech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashi Agarwal  | Director | 12-Mar-2013 | Current |
| Nishant Agarwal | Director | 12-Mar-2013 | Current |
| Sanjay Agarwal | Director | 12-Mar-2013 | Current |
| Anubha Agarwal | Director | 29-May-2019 | Current |
Financial Performance of Srn Meditech.
Srn Meditech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.41% decrease. The company also saw a slight decrease in profitability, with a 1.11% decrease in profit. The company's net worth Soared by an impressive increase of 10.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srn Meditech?
In 2023, Srn Meditech had a public holding of 32.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nexokinde Healthcare Private LimitedNishant Agarwal and Anubha Agarwal are mutual person
Charges (Loans)
Open Charges
₹3.00 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2024 | Indian Bank | ₹3.00 Cr | Open |
How Many Employees Work at Srn Meditech?
Unlock and access historical data on people associated with Srn Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srn Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srn Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
